Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells 1,202 Shares of Stock
Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Curet Myriam sold 1,202 shares of the company’s stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $950.20, for a total value of $1,142,140.40. Following the sale, the senior vice president now owns 1,428 shares of the company’s stock, valued at $1,356,885.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Curet Myriam also recently made the following trade(s):
- On Wednesday, June 7th, Curet Myriam sold 750 shares of Intuitive Surgical stock. The stock was sold at an average price of $930.00, for a total value of $697,500.00.
- On Monday, June 5th, Curet Myriam sold 2,644 shares of Intuitive Surgical stock. The stock was sold at an average price of $921.26, for a total value of $2,435,811.44.
- On Tuesday, May 2nd, Curet Myriam sold 3,385 shares of Intuitive Surgical stock. The stock was sold at an average price of $837.21, for a total value of $2,833,955.85.
Shares of Intuitive Surgical, Inc. (NASDAQ ISRG) traded down 0.45% on Tuesday, hitting $944.92. The stock had a trading volume of 356,565 shares. Intuitive Surgical, Inc. has a 12-month low of $610.71 and a 12-month high of $974.66. The company has a market cap of $35.10 billion, a price-to-earnings ratio of 45.26 and a beta of 0.39. The stock has a 50 day moving average price of $935.86 and a 200-day moving average price of $809.08.
Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $5.79 by $0.16. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The business had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. During the same period in the previous year, the business earned $5.62 EPS. The business’s quarterly revenue was up 12.8% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical, Inc. will post $23.86 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/07/25/insider-selling-intuitive-surgical-inc-nasdaqisrg-svp-sells-1202-shares-of-stock.html.
Several hedge funds have recently bought and sold shares of ISRG. D. Scott Neal Inc. purchased a new stake in Intuitive Surgical during the second quarter valued at $120,000. Guardian Life Insurance Co. of America increased its stake in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares during the last quarter. Acropolis Investment Management LLC purchased a new stake in Intuitive Surgical during the first quarter valued at $115,000. Parallel Advisors LLC increased its stake in Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares during the last quarter. Finally, Huntington National Bank increased its stake in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares during the last quarter. 97.56% of the stock is owned by institutional investors and hedge funds.
A number of equities research analysts recently weighed in on ISRG shares. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price objective for the company in a research note on Monday, April 24th. Wedbush upped their price objective on Intuitive Surgical from $835.00 to $875.00 and gave the stock an “outperform” rating in a research note on Monday, April 24th. Leerink Swann restated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, July 5th. Barclays PLC upped their price objective on Intuitive Surgical from $870.00 to $1,000.00 and gave the stock an “overweight” rating in a research note on Friday. They noted that the move was a valuation call. Finally, Morgan Stanley set a $950.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Monday, May 22nd. Six research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Intuitive Surgical currently has an average rating of “Buy” and an average price target of $972.39.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.